Milestone Scientific Announces Commercial Rollout Of CompuFlo Epidural System At iHeal Pain Center Following Medicare Price Assignment
Portfolio Pulse from Benzinga Newsdesk
Milestone Scientific Inc. (NYSE:MLSS) has announced the commercial rollout of its CompuFlo Epidural System at iHeal Pain Center, following successful procedures and a favorable Medicare price assignment. This marks a significant step in their commercial activities, supported by a strategic partnership with Axial Biologics.
October 03, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Milestone Scientific's CompuFlo Epidural System is now commercially available at iHeal Pain Center, supported by a Medicare price assignment and a partnership with Axial Biologics. This could enhance MLSS's market presence and revenue potential.
The commercial rollout of the CompuFlo Epidural System at iHeal Pain Center, combined with a favorable Medicare price assignment, is likely to boost Milestone Scientific's market presence and revenue. The strategic partnership with Axial Biologics further supports the adoption of the system, indicating a positive short-term impact on MLSS's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100